Liothyronine sodium 20 mcg Oral Tablet
RxNorm 903701
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 903701 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: liothyronine sodium 20 mcg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Liothyronine sodium 0.02 mg Oral Tablet
(Atom ID: 3065366)
PSN
Prescribable Name (PSN):
Liothyronine sodium 20 mcg Oral Tablet
(Atom ID: 6365924)
SY
Synonym (SY):
Liothyronine sodium 20 mcg Oral Tablet
(Atom ID: 3065367)
PT
Designated preferred name (PT):
Liothyronine sodium 20 microgram oral tablet
(Atom ID: 10300989)
FN
Full form of descriptor (FN):
Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10314295)
Patient Education
Liothyronine
Liothyronine is used to treat hypothyroidism (a condition where the thyroid gland does not produce enough thyroid hormone). Liothyronine is also used to treat a goiter (an enlarged thyroid gland) and to test for hyperthyroidism (a condition where the thyroid gland produces too much thyroid hormone). Liothyronine is in a class of medications called thyroid agents. It works by supplying the thyroid hormones normally produced by the body. Currently, there is not enough evidence from clinical studies to support the use of liothyronine, alone or in combination with other medications, as the first choice of therapy to treat hypothyroidism.
[Learn More]
* Please review the disclaimer below.